دورية أكاديمية
أعرض في EDS

Predictive Antibiotic Susceptibility Testing by Next-Generation Sequencing for Periprosthetic Joint Infections: Potential and Limitations.

التفاصيل البيبلوغرافية
العنوان: Predictive Antibiotic Susceptibility Testing by Next-Generation Sequencing for Periprosthetic Joint Infections: Potential and Limitations.
المؤلفون: Lüftinger L; Ares Genetics GmbH, Karl-Farkas-Gasse 18, 1030 Vienna, Austria.; Division of Computational Systems Biology, Department of Microbiology and Ecosystem Science, University of Vienna, 1030 Vienna, Austria., Ferreira I; Ares Genetics GmbH, Karl-Farkas-Gasse 18, 1030 Vienna, Austria.; Center for Integrative Bioinformatics Vienna, Max Perutz Laboratories, University of Vienna, 1030 Vienna, Austria.; Center for Integrative Bioinformatics Vienna, Max Perutz Laboratories, Medical University of Vienna, 1030 Vienna, Austria., Frank BJH; Michael Ogon Laboratory for Orthopaedic Research, Orthopaedic Hospital Vienna-Speising, 1130 Vienna, Austria., Beisken S; Ares Genetics GmbH, Karl-Farkas-Gasse 18, 1030 Vienna, Austria., Weinberger J; Ares Genetics GmbH, Karl-Farkas-Gasse 18, 1030 Vienna, Austria., von Haeseler A; Center for Integrative Bioinformatics Vienna, Max Perutz Laboratories, University of Vienna, 1030 Vienna, Austria.; Center for Integrative Bioinformatics Vienna, Max Perutz Laboratories, Medical University of Vienna, 1030 Vienna, Austria.; Bioinformatics and Computational Biology, Faculty of Computer Science, University of Vienna, 1090 Vienna, Austria., Rattei T; Division of Computational Systems Biology, Department of Microbiology and Ecosystem Science, University of Vienna, 1030 Vienna, Austria., Hofstaetter JG; Michael Ogon Laboratory for Orthopaedic Research, Orthopaedic Hospital Vienna-Speising, 1130 Vienna, Austria., Posch AE; Ares Genetics GmbH, Karl-Farkas-Gasse 18, 1030 Vienna, Austria., Materna A; Ares Genetics GmbH, Karl-Farkas-Gasse 18, 1030 Vienna, Austria.
المصدر: Biomedicines [Biomedicines] 2021 Jul 29; Vol. 9 (8). Date of Electronic Publication: 2021 Jul 29.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2013]-
مستخلص: Joint replacement surgeries are one of the most frequent medical interventions globally. Infections of prosthetic joints are a major health challenge and typically require prolonged or even indefinite antibiotic treatment. As multidrug-resistant pathogens continue to rise globally, novel diagnostics are critical to ensure appropriate treatment and help with prosthetic joint infections (PJI) management. To this end, recent studies have shown the potential of molecular methods such as next-generation sequencing to complement established phenotypic, culture-based methods. Together with advanced bioinformatics approaches, next-generation sequencing can provide comprehensive information on pathogen identity as well as antimicrobial susceptibility, potentially enabling rapid diagnosis and targeted therapy of PJIs. In this review, we summarize current developments in next generation sequencing based predictive antibiotic susceptibility testing and discuss potential and limitations for common PJI pathogens.
References: Biotechnol Adv. 2019 Jan - Feb;37(1):177-192. (PMID: 30500353)
J Antimicrob Chemother. 2020 Dec 1;75(12):3491-3500. (PMID: 32780112)
J Arthroplasty. 2012 Sep;27(8 Suppl):61-5.e1. (PMID: 22554729)
Sci Rep. 2018 Jan 11;8(1):421. (PMID: 29323230)
Cancer Biol Med. 2019 Feb;16(1):4-10. (PMID: 31119042)
Microb Genom. 2017 Sep 4;3(10):e000131. (PMID: 29177089)
Microbiol Spectr. 2017 Dec;5(6):. (PMID: 29219107)
Sci Rep. 2017 Aug 10;7(1):7718. (PMID: 28798333)
Hip Int. 2020 Sep;30(1_suppl):72-77. (PMID: 32907419)
Clin Infect Dis. 2009 Oct 1;49(7):1036-43. (PMID: 19691430)
mBio. 2016 Jun 14;7(3):. (PMID: 27302760)
Clin Microbiol Infect. 2019 Sep;25(9):1071-1080. (PMID: 30502487)
Nat Methods. 2017 Nov;14(11):1063-1071. (PMID: 28967888)
J Clin Microbiol. 2018 Aug 27;56(9):. (PMID: 29848568)
PLoS Comput Biol. 2018 Oct 22;14(10):e1006434. (PMID: 30346947)
J Clin Virol. 2019 Jan;110:11-16. (PMID: 30502640)
Knee Surg Sports Traumatol Arthrosc. 2021 Oct;29(10):3287-3298. (PMID: 32671435)
J Bone Joint Surg Am. 2018 Sep 5;100(17):1455-1460. (PMID: 30180053)
J Infect Public Health. 2016 Jul-Aug;9(4):494-8. (PMID: 26829894)
Clin Infect Dis. 2005 Jul 15;41 Suppl 2:S120-6. (PMID: 15942878)
J Antimicrob Chemother. 2013 Oct;68(10):2234-44. (PMID: 23722448)
J Antimicrob Chemother. 2013 Apr;68(4):771-7. (PMID: 23233485)
Biology (Basel). 2020 Oct 28;9(11):. (PMID: 33126516)
Front Med (Lausanne). 2020 Oct 26;7:513242. (PMID: 33195289)
Nat Rev Cancer. 2008 Jan;8(1):37-49. (PMID: 18097463)
Front Public Health. 2019 Sep 04;7:242. (PMID: 31552211)
Bone Joint J. 2017 May;99-B(5):653-659. (PMID: 28455475)
Lancet. 2001 May 26;357(9269):1674-5. (PMID: 11425376)
J Bone Jt Infect. 2016 Jun 4;1:25-30. (PMID: 28529849)
mBio. 2018 Oct 23;9(5):. (PMID: 30352937)
Nat Rev Genet. 2015 Jun;16(6):321-32. (PMID: 25948244)
EMBO Mol Med. 2020 Mar 6;12(3):e10264. (PMID: 32048461)
Sci Rep. 2016 Jun 14;6:27930. (PMID: 27297683)
J Clin Lab Anal. 2020 Aug;34(8):e23348. (PMID: 32358872)
Nat Microbiol. 2020 Mar;5(3):455-464. (PMID: 32042129)
Clin Microbiol Infect. 2019 Jun;25(6):717-722. (PMID: 30287414)
Biomol Detect Quantif. 2017 Oct 23;14:1-6. (PMID: 29255684)
J Antimicrob Chemother. 2016 Sep;71(9):2484-8. (PMID: 27365186)
Sci Rep. 2019 Mar 11;9(1):4071. (PMID: 30858411)
Clin Microbiol Rev. 2014 Apr;27(2):302-45. (PMID: 24696437)
EFORT Open Rev. 2019 Jul 29;4(7):482-494. (PMID: 31423332)
J Clin Microbiol. 2021 Feb 18;59(3):. (PMID: 33328178)
Ann Pharmacother. 2015 Jan;49(1):69-85. (PMID: 25352037)
Curr Protoc Mol Biol. 2015 Oct 01;112:7.21.1-7.21.23. (PMID: 26423591)
J Clin Microbiol. 2019 Jan 30;57(2):. (PMID: 30333126)
J Antimicrob Chemother. 2020 Nov 1;75(11):3099-3108. (PMID: 32658975)
PLoS Comput Biol. 2018 Dec 14;14(12):e1006258. (PMID: 30550564)
Front Microbiol. 2016 Nov 28;7:1887. (PMID: 27965630)
BMJ Glob Health. 2020 Nov;5(11):. (PMID: 33239336)
Brief Funct Genomics. 2013 Jul;12(4):305-15. (PMID: 23430683)
FEMS Microbiol Rev. 2017 May 1;41(3):430-449. (PMID: 28419231)
J Microbiol Methods. 2014 Oct;105:16-21. (PMID: 25014253)
Clin Microbiol Rev. 2014 Oct;27(4):870-926. (PMID: 25278577)
J Clin Microbiol. 2019 May 24;57(6):. (PMID: 30894438)
Clin Infect Dis. 2009 Dec 1;49(11):1749-55. (PMID: 19857164)
J Clin Microbiol. 2014 Apr;52(4):1182-91. (PMID: 24501024)
BMC Genomics. 2016 Sep 26;17(1):754. (PMID: 27671088)
Ann N Y Acad Sci. 2019 Jan;1435(1):5-17. (PMID: 28574575)
J Mol Biol. 1990 Oct 5;215(3):403-10. (PMID: 2231712)
PLoS Comput Biol. 2019 Sep 3;15(9):e1007349. (PMID: 31479500)
Front Cell Infect Microbiol. 2021 Feb 15;11:610348. (PMID: 33659219)
Nat Commun. 2015 Dec 21;6:10063. (PMID: 26686880)
Int Orthop. 2020 Jul;44(7):1255-1261. (PMID: 32449042)
معلومات مُعتمدة: 24478239 Wirtschaftsagentur Wien
فهرسة مساهمة: Keywords: NGS; antibiotic susceptibility testing; machine learning; periprosthetic joint infection
تواريخ الأحداث: Date Created: 20210827 Latest Revision: 20240814
رمز التحديث: 20240814
مُعرف محوري في PubMed: PMC8389688
DOI: 10.3390/biomedicines9080910
PMID: 34440114
قاعدة البيانات: MEDLINE
الوصف
تدمد:2227-9059
DOI:10.3390/biomedicines9080910